Dr. Amit Gupta, MD

Dr. Gupta practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Gupta's NPI, 1548464332, was assigned on June 13, 2007. Dr. Gupta graduated from All India Institute of Medical Sciences in 2002. Dr. Gupta holds California license C142651.

Dr. Gupta's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Gupta's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dmand AI also links Dr. Gupta to 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gupta is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gupta's licenses on file in 2 states: California and Iowa.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer and prostate surgery among the conditions Dr. Gupta treats.

CMS data shows 2,620 Medicare services from Dr. Gupta across 24 procedure codes in 2024, for 285 Medicare patients. Medicare paid $188,899 for them.

CMS counts 285 Medicare patients who saw Dr. Gupta in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 72, with 22% women.

In 2024, Dr. Gupta wrote 588 Medicare Part D claims for 130 patients. 80% of them were for generic drugs. CMS names the drug for 513 of them, across 9 drugs with 11 or more claims each, at $82,546 in total drug cost. In 2023, CMS named 700 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gupta for performance year 2024, reported individually. Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Gupta, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Gupta, published from 2010 to 2025. Dr. Gupta's most frequent co-authors are Amar Gupta, MD, Irene K. Kim, MD and John Michael Masterson, MD.

CMS Open Payments shows 150 general payments to Dr. Gupta from 29 drug and device companies from 2016 to 2025. Education make up the largest share, 35% of the total. Intuitive Surgical, Inc. paid the most, $34,120.

Dr. Gupta graduated from All India Institute of Medical Sciences in 2002. Dr. Gupta is a member of ASCO, American Urological Association and Society of Urologic Oncology.

Dr. Gupta is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.